WBR0273: Difference between revisions
Sergekorjian (talk | contribs) No edit summary |
Sergekorjian (talk | contribs) No edit summary |
||
Line 22: | Line 22: | ||
|SubCategory=Endocrine | |SubCategory=Endocrine | ||
|Prompt=A 53 year-old man comes to the clinic after noticing several bluish stretch marks on his abdomen. He has a history of autoimmune hepatitis treated with daily 20 mg of prednisone for the past 8 months. He complains of weight gain and difficulty climbing stairs because his legs feel weak. His blood pressure is 150/72 mm Hg, heart rate is 86/min, and temperature is 36.6 ᵒC (98 ᵒF). On exam, you notice thick bluish striae on the abdomen, round, full facies, and extra fat around the neck and upper part of the back. Which of the following is correct about the hormone causing this patient’s syndrome? | |Prompt=A 53 year-old man comes to the clinic after noticing several bluish stretch marks on his abdomen. He has a history of autoimmune hepatitis treated with daily 20 mg of prednisone for the past 8 months. He complains of weight gain and difficulty climbing stairs because his legs feel weak. His blood pressure is 150/72 mm Hg, heart rate is 86/min, and temperature is 36.6 ᵒC (98 ᵒF). On exam, you notice thick bluish striae on the abdomen, round, full facies, and extra fat around the neck and upper part of the back. Which of the following is correct about the hormone causing this patient’s syndrome? | ||
|Explanation=Prednisone is a more potent formulation of the endogenous glucocorticoid cortisol. With chronic administration, patients develop characteristic changes associated with excess glucocorticoids known as Cushing's syndrome. Patients classically have symptoms of weight gain, abdominal obesity, and proximal muscle weakness. Physical exam reveals peripheral muscle atrophy, acanthosis nigricans, dorsocervical fat pad (buffalo hump), and purple abdominal skin striae. Patients are at increased risk for osteoporosis. | |||
Glucocorticoids have several functions most important of which relates to suppression of the immune system. Glucocorticoids cause arrest of all pro-inflammatory pathways leading to a decrease in leukotrienes and prosaglandins, inhibition of histamine release, decrease in eosinophils and lymphocyes, and inhibition of leukocyte adhesion (cause for peripheral neutrophilia). Other functions include maintenance of blood pressure and increase in lipolysis and gluconeogenesis. | |||
Glucocorticoids also alter the production of cytokines causing a decrease in pro-inflammatory molecules such as IL-1, IL-2, IL-6 and an increase in anti-inflammatory or regulatory cytokines such as IL-10 and TGF-β. | |||
|AnswerA=Promotes leukotrienes production | |AnswerA=Promotes leukotrienes production | ||
|AnswerAExp=Glucocorticoids cause a decrease in leukotriene production. | |||
|AnswerB=Promotes leukocyte adhesion | |AnswerB=Promotes leukocyte adhesion | ||
|AnswerBExp=Glucocorticoids inhibit leukocyte adhesion, leading to increased circulating neutrophils accounting for the neutrophilia documented on blood examination. | |||
|AnswerC=Increases IL-10 production | |AnswerC=Increases IL-10 production | ||
|AnswerCExp=Glucocorticoids cause an increase in anti-inflammatory cytokines such as IL-10 and TGF-β. | |||
|AnswerD=Increases eosinophils | |AnswerD=Increases eosinophils | ||
|AnswerDExp=Glucocorticoids cause a decrease in circulating eosinophils and decreases eosinophil production. | |||
|AnswerE=Promotes neutropenia | |AnswerE=Promotes neutropenia | ||
|AnswerEExp=By inhibiting leukocyte adhesion, glucocorticoids causes an increase in circulating neutrophils leading to neutrophilia rather than neutropenia. | |||
|EducationalObjectives=Glucocorticoid therapy causes an increase in anti-inflammatory cytokines such as | |||
|References=Nakagawa M, Terashima T, D'yachkova Y, Bondy GP, Hogg JC, Van eeden SF. Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes. Circulation. 1998;98(21):2307-13.<br> | |||
Hoes JN, Jacobs JW, Verstappen SM, Bijlsma JW, Van der heijden GJ. Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis. Ann Rheum Dis. 2009;68(12):1833-8. | |||
|RightAnswer=C | |RightAnswer=C | ||
|WBRKeyword=Glucocorticoids, prednisone, IL-10, Cortisol, Cushing's syndrome, | |||
|Approved=No | |Approved=No | ||
}} | }} |
Revision as of 19:20, 30 July 2014
Author | [[PageAuthor::Gonzalo A. Romero, M.D. [1] (Reviewed by Serge Korjian)]] |
---|---|
Exam Type | ExamType::USMLE Step 1 |
Main Category | MainCategory::Immunology, MainCategory::Pathophysiology, MainCategory::Physiology |
Sub Category | SubCategory::Endocrine |
Prompt | [[Prompt::A 53 year-old man comes to the clinic after noticing several bluish stretch marks on his abdomen. He has a history of autoimmune hepatitis treated with daily 20 mg of prednisone for the past 8 months. He complains of weight gain and difficulty climbing stairs because his legs feel weak. His blood pressure is 150/72 mm Hg, heart rate is 86/min, and temperature is 36.6 ᵒC (98 ᵒF). On exam, you notice thick bluish striae on the abdomen, round, full facies, and extra fat around the neck and upper part of the back. Which of the following is correct about the hormone causing this patient’s syndrome?]] |
Answer A | AnswerA::Promotes leukotrienes production |
Answer A Explanation | AnswerAExp::Glucocorticoids cause a decrease in leukotriene production. |
Answer B | AnswerB::Promotes leukocyte adhesion |
Answer B Explanation | AnswerBExp::Glucocorticoids inhibit leukocyte adhesion, leading to increased circulating neutrophils accounting for the neutrophilia documented on blood examination. |
Answer C | AnswerC::Increases IL-10 production |
Answer C Explanation | AnswerCExp::Glucocorticoids cause an increase in anti-inflammatory cytokines such as IL-10 and TGF-β. |
Answer D | AnswerD::Increases eosinophils |
Answer D Explanation | AnswerDExp::Glucocorticoids cause a decrease in circulating eosinophils and decreases eosinophil production. |
Answer E | AnswerE::Promotes neutropenia |
Answer E Explanation | AnswerEExp::By inhibiting leukocyte adhesion, glucocorticoids causes an increase in circulating neutrophils leading to neutrophilia rather than neutropenia. |
Right Answer | RightAnswer::C |
Explanation | [[Explanation::Prednisone is a more potent formulation of the endogenous glucocorticoid cortisol. With chronic administration, patients develop characteristic changes associated with excess glucocorticoids known as Cushing's syndrome. Patients classically have symptoms of weight gain, abdominal obesity, and proximal muscle weakness. Physical exam reveals peripheral muscle atrophy, acanthosis nigricans, dorsocervical fat pad (buffalo hump), and purple abdominal skin striae. Patients are at increased risk for osteoporosis.
Glucocorticoids have several functions most important of which relates to suppression of the immune system. Glucocorticoids cause arrest of all pro-inflammatory pathways leading to a decrease in leukotrienes and prosaglandins, inhibition of histamine release, decrease in eosinophils and lymphocyes, and inhibition of leukocyte adhesion (cause for peripheral neutrophilia). Other functions include maintenance of blood pressure and increase in lipolysis and gluconeogenesis. Glucocorticoids also alter the production of cytokines causing a decrease in pro-inflammatory molecules such as IL-1, IL-2, IL-6 and an increase in anti-inflammatory or regulatory cytokines such as IL-10 and TGF-β. |
Approved | Approved::No |
Keyword | WBRKeyword::Glucocorticoids, WBRKeyword::prednisone, WBRKeyword::IL-10, WBRKeyword::Cortisol, WBRKeyword::Cushing's syndrome |
Linked Question | Linked:: |
Order in Linked Questions | LinkedOrder:: |